共 50 条
- [42] Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 194
- [48] Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer British Journal of Cancer, 2010, 103 : 462 - 468